| |||||||||||||||
| CD22 deficient mutant mice exhibit a reduction in recirculating mature B cells in the bone marrow and fewer transitional B cells in the spleen. Splenic and peripheral B cells express lower levels of membrane bound IgM than wildtype. B cell activation is abnormal in mutant mice, with enhanced Ca2+ mobilization after stimulation. This mutant mouse strain may be useful in studies of glycosidic molecular interactions and function, B cell development and T cell independent immune response. | |||||||||||||||
Type Coisogenic; Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Mating System Homozygote x Homozygote (Female x Male) 18-NOV-08 Species laboratory mouse Generation F?+2 (12-JAN-09) Donating Investigator Lars Nitschke, Max-Planck Institute for Immunobiology Description
Mice that are homozygous for the targeted mutation are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities. No expression of the targeted gene's protein product is detected on the cell surface, as determined by flow cytometry analysis of splenocytes from homozygotes. Mutants exhibit a reduction in recirculating mature B cells in the bone marrow and fewer transitional B cells in the spleen. Splenic and peripheral B cells express lower levels of membrane bound IgM than wildtype. B cell activation is abnormal in mutant mice, with enhanced Ca2+ mobilization after stimulation. Lipopolysaccaharide (LPS) challenge results in an increased proliferative response. CD22 deficient B cells have a shorter than average lifespan when compared to wildtype B cells. T-cell independent immune responses are impaired. This mutant mouse strain may be useful in studies of glycosidic molecular interactions and function, B cell development and T cell independent immune response.This strain was transferred from the collection of the Consortium for Functional Glycomics.
Development
A targeting vector containing neomycin resistance and herpes simplex virus thymidine kinase genes was used to disrupt exon11, which encodes the transmembrane domain. The construct was electroporated into C57BL/6 derived BL/6-III embryonic stem (ES) cells.Correctly targeted ES cells were injected into recipient blastocysts. The mice were backcrossed to the C57BL/6 background for 10 generations before arriving at The Jackson Laboratory.
| Control | ||
|---|---|---|
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Cd22tm1Lam/Cd22tm1Lam
involves: 129 * C57BL/6
- immune system phenotype
- abnormal B cell activation (MGI Ref ID J:125719)
- enhanced Ca2+ mobilization upon activation of B cells
- decreased mature B cell number (MGI Ref ID J:125719)
- reduction of recirculating mature B cells in the bone marrow
- decreased marginal zone B cell number (MGI Ref ID J:125719)
- reduced by 20%
- hematopoietic system phenotype
- abnormal B cell activation (MGI Ref ID J:125719)
- enhanced Ca2+ mobilization upon activation of B cells
- decreased mature B cell number (MGI Ref ID J:125719)
- reduction of recirculating mature B cells in the bone marrow
- decreased marginal zone B cell number (MGI Ref ID J:125719)
- reduced by 20%
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
Cell Biology Research
Protein Processing
Immunology and Inflammation Research
Immunodeficiency
B cell deficiency
| Allele Symbol | Cd22tm1Lam | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Marinus C Lamers | ||
| Allele Type | Targeted (knock-out) | ||
| Common Name(s) | CD22-; | ||
| Mutation Made By | Peter Sobieszczuk, Consortium for Functional Glycomics,TSRI | ||
| Strain of Origin | C57BL/6 | ||
| ES Cell Line Name | BL/6-III | ||
| ES Cell Line Strain | C57BL/6 | ||
| Gene Symbol and Name | Cd22, CD22 antigen | ||
| Chromosome | 7 | ||
| Gene Common Name(s) | B-lymphocyte antigen 8; FLJ22814; Lyb-8; Lyb8; MGC130020; SIGLEC-2; SIGLEC2; | ||
| Molecular Note | Exon 11, encoding the transmembrane domain, was disrupted by the insertion of a neomycin cassette. Flow cytometric analysis showed an absence of surface expression on splenocytes isolated from homozygous mutant mice. [MGI Ref ID J:38644] | ||
Genotyping Protocols
Cd22tm1Lam, Standard PCR
Helpful Links
Genotyping resources and troubleshooting
Nitschke L; Carsetti R; Ocker B; Kohler G; Lamers MC. 1997. CD22 is a negative regulator of B-cell receptor signalling. Curr Biol 7(2):133-43. [PubMed: 9016707] [MGI Ref ID J:38644]
Cd22tm1Lam relatedAmano H; Amano E; Moll T; Marinkovic D; Ibnou-Zekri N; Martinez-Soria E; Semac I; Wirth T; Nitschke L; Izui S. 2003. The yaa mutation promoting murine lupus causes defective development of marginal zone B cells. J Immunol 170(5):2293-301. [PubMed: 12594250] [MGI Ref ID J:82017]
Ashton AW; Mukherjee S; Nagajyothi FN; Huang H; Braunstein VL; Desruisseaux MS; Factor SM; Lopez L; Berman JW; Wittner M; Scherer PE; Capra V; Coffman TM; Serhan CN; Gotlinger K; Wu KK; Weiss LM; Tanowitz HB. 2007. Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection. J Exp Med 204(4):929-40. [PubMed: 17420269] [MGI Ref ID J:125718]
Collins BE; Smith BA; Bengtson P; Paulson JC. 2006. Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling. Nat Immunol 7(2):199-206. [PubMed: 16369536] [MGI Ref ID J:112390]
Ghosh S; Bandulet C; Nitschke L. 2006. Regulation of B cell development and B cell signalling by CD22 and its ligands {alpha}2,6-linked sialic acids. Int Immunol 18(4):603-11. [PubMed: 16497829] [MGI Ref ID J:107062]
Grewal PK; Boton M; Ramirez K; Collins BE; Saito A; Green RS; Ohtsubo K; Chui D; Marth JD. 2006. ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling. Mol Cell Biol 26(13):4970-81. [PubMed: 16782884] [MGI Ref ID J:110325]
Lajaunias F; Nitschke L; Moll T; Martinez-Soria E; Semac I; Chicheportiche Y; Parkhouse RM; Izui S. 2002. Differentially regulated expression and function of CD22 in activated B-1 and B-2 lymphocytes. J Immunol 168(12):6078-83. [PubMed: 12055217] [MGI Ref ID J:123796]
Moll T; Nitschke L; Carroll M; Ravetch JV; Izui S. 2004. A critical role for Fc gamma RIIB in the induction of rheumatoid factors. J Immunol 173(7):4724-8. [PubMed: 15383609] [MGI Ref ID J:93718]
Nitschke L; Floyd H; Ferguson DJ; Crocker PR. 1999. Identification of CD22 ligands on bone marrow sinusoidal endothelium implicated in CD22-dependent homing of recirculating B cells. J Exp Med 189(9):1513-8. [PubMed: 10224292] [MGI Ref ID J:76972]
Nitschke L; Lajaunias F; Moll T; Ho L; Martinez-Soria E; Kikuchi S; Santiago-Raber ML; Dix C; Parkhouse RM; Izui S. 2006. Expression of aberrant forms of CD22 on B lymphocytes in Cd22a lupus-prone mice affects ligand binding. Int Immunol 18(1):59-68. [PubMed: 16291654] [MGI Ref ID J:104168]
Samardzic T; Gerlach J; Muller K; Marinkovic D; Hess J; Nitschke L; Wirth T. 2002. CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice. Eur J Immunol 32(9):2481-9. [PubMed: 12207332] [MGI Ref ID J:78999]
Samardzic T; Marinkovic D; Danzer CP; Gerlach J; Nitschke L; Wirth T. 2002. Reduction of marginal zone B cells in CD22-deficient mice. Eur J Immunol 32(2):561-7. [PubMed: 11828373] [MGI Ref ID J:74752]
Waisman A; Kraus M; Seagal J; Ghosh S; Melamed D; Song J; Sasaki Y; Classen S; Lutz C; Brombacher F; Nitschke L; Rajewsky K. 2007. IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha/beta. J Exp Med 204(4):747-58. [PubMed: 17420268] [MGI Ref ID J:125719]
Animal Health Reports
Room Number AX12
Colony Maintenance
Breeding & Husbandry When maintaining a live colony, these mice can be bred as homozygotes. Mating System Homozygote x Homozygote (Female x Male) 18-NOV-08 Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
Weeks of Age Price (US dollars $) Gender Genotypes Provided Individual Mouse $160.40 Female or Male Homozygous for Cd22tm1Lam
Pairs /Price (US dollars $) Pair Genotype $320.80 Homozygous for Cd22tm1Lam x Homozygous for Cd22tm1Lam
| Pricing for International shipping destinations |
|
Weeks of Age Price (US dollars $) Gender Genotypes Provided Individual Mouse $208.60 Female or Male Homozygous for Cd22tm1Lam
Pairs /Price (US dollars $) Pair Genotype $417.10 Homozygous for Cd22tm1Lam x Homozygous for Cd22tm1Lam
| Standard Supply | Repository-Live. A collection of over 1000 strains maintained as live colonies. Individual colonies are sized to meet current customer demand. Delivery for orders of 10 mice or less ranges on average from one to eight weeks; mice are generally shipped between four to six weeks of age with a maximum shipping age of approximately nine weeks. Colony sizes do not generally support stringent age specifications for large volumes of mice; however custom orders and larger quantities of mice are easily arranged. Estimated ship dates for all orders provided within two business days following order placement. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 1-800-422-6423 or 1-207-288-5845
Fax: 1-207-288-6150
Technical Support Email Form
For Licensing and Use Restrictions view the link(s) below:
- Strain(s) not available to companies or for-profit entities.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. In purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.